Drug class in one race
CD73 drugs for Non-Small Cell Lung Cancer
4 tracked CD73 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the CD73 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 31 Phase 2/31 Phase 1/21 Phase 1
Head-to-head evidence: CPI-006 vs Oleclumab · CPI-006 vs PT199 · CPI-006 vs Uliledlimab · Oleclumab vs PT199 · Oleclumab vs Uliledlimab